These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22874667)

  • 41. Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides.
    Lopes JP; Oliveira CR; Agostinho P
    Cell Cycle; 2009 Jan; 8(1):97-104. PubMed ID: 19158499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S-nitrosylation of ApoE in Alzheimer's disease.
    Abrams AJ; Farooq A; Wang G
    Biochemistry; 2011 May; 50(17):3405-7. PubMed ID: 21443265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.
    Posada-Duque RA; López-Tobón A; Piedrahita D; González-Billault C; Cardona-Gomez GP
    J Neurochem; 2015 Jul; 134(2):354-70. PubMed ID: 25864429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of CDK5/P25 formation/inhibition in neurodegeneration.
    Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
    Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of the drebrin/EB3/Cdk5 pathway in dendritic spine plasticity, implications for Alzheimer's disease.
    Gordon-Weeks PR
    Brain Res Bull; 2016 Sep; 126(Pt 3):293-299. PubMed ID: 27365229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cdk5, a therapeutic target for Alzheimer's disease?
    Tsai LH; Lee MS; Cruz J
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):137-42. PubMed ID: 15023356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.
    Kandimalla R; Reddy PH
    Biochim Biophys Acta; 2016 Apr; 1862(4):814-828. PubMed ID: 26708942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
    Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
    J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis.
    Meuer K; Suppanz IE; Lingor P; Planchamp V; Göricke B; Fichtner L; Braus GH; Dietz GP; Jakobs S; Bähr M; Weishaupt JH
    Cell Death Differ; 2007 Apr; 14(4):651-61. PubMed ID: 17218957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
    Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
    Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
    Orellana DI; Quintanilla RA; Maccioni RB
    Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S-nitrosylation-dependent proteasomal degradation restrains Cdk5 activity to regulate hippocampal synaptic strength.
    Zhang P; Fu WY; Fu AK; Ip NY
    Nat Commun; 2015 Oct; 6():8665. PubMed ID: 26503494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.
    Ryu IH; Lee KY; Do SI
    Biochim Biophys Acta; 2016 May; 1864(5):609-21. PubMed ID: 26854602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysfunctional Mitochondrial Dynamics in the Pathophysiology of Neurodegenerative Diseases.
    Haun F; Nakamura T; Lipton SA
    J Cell Death; 2013; 6():27-35. PubMed ID: 24587691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
    Han P; Dou F; Li F; Zhang X; Zhang YW; Zheng H; Lipton SA; Xu H; Liao FF
    J Neurosci; 2005 Dec; 25(50):11542-52. PubMed ID: 16354912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Berberine attenuates Aβ-induced neuronal damage through regulating miR-188/NOS1 in Alzheimer's disease.
    Chen M; Li L; Liu C; Song L
    Mol Cell Biochem; 2020 Nov; 474(1-2):285-294. PubMed ID: 32779043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Golgi fragmentation induced by overactivated cyclin-dependent kinase 5 is associated with isoflurane-induced neurotoxicity.
    Miao FF; Kong CC; Wu Y; Fan L; Wang TL
    Neuroreport; 2018 Mar; 29(4):241-246. PubMed ID: 29227343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.